HGH (Somatropin): FDA-approved for specific indications: pediatric growth hormone deficiency, adult GHD, Turner syndrome, HIV/AIDS-related wasting, short bowel syndrome Prescription-only medication requiring physician monitoring Illegal to distribute for off-label purposes including anti-aging (per the 1990 Anabolic Steroids Control Act amendments) Brand names include Genotropin, Norditropin, Humatrope, Saizen CJC-1295 and Ipamorelin: Neither is FDA-approved for any therapeutic indication Available as research compounds for laboratory use only (RUO Research Use Only) Not scheduled substances, but not approved for human therapeutic use Ipamorelin has undergone Phase I/II clinical trials (Johansen et al., 1999) but development did not progress to approval For a deeper look at Ipamorelin's regulatory history, see our Ipamorelin FDA approval status guide
Compounds appearing in fewer than 20% of Alabama listings including MOTS-c, Tesamorelin, MK-677 are less commonly disclosed
95% CI 0.560.79), and MAKEs (aHR 0.66
Together, they could deliver weight loss that is both substantial and composition-favorable
Most patients report reduced food cravings and improved portion control within 24 weeks of starting therapy
If refill purchase is completed more than 45 days after the delivery/receipt of your previous Foundayo prescription, purchase offer will not apply